Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

L'Effetto Dell'Anestesia A Basso Flusso E Ad Alto Flusso Sulla Pressione Intracranica

9 novembre 2026 aggiornato da: Yasin Karabacak, Bursa City Hospital

Effetti Comparativi dell'Anestesia ad Alto Flusso e a Basso Flusso sul Diametro della Guaina del Nervo Ottico e sull'Ossigenazione Cerebrale Durante l'Isterectomia Laparoscopica

This prospective randomized study was conducted to evaluate the effects of low-flow and high-flow anesthesia on intracranial dynamics and cerebral oxygenation in patients undergoing laparoscopic hysterectomy in the Trendelenburg position. Intracranial pressure was assessed noninvasively using optic nerve sheath diameter (ONSD), and cerebral oxygenation was monitored using near-infrared spectroscopy (NIRS). Changes in these parameters were assessed under standardized pneumoperitoneum and positioning conditions, and comparisons between anesthesia flow groups were performed according to the predefined study protocol.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Laparoscopic surgical procedures commonly involve the establishment of pneumoperitoneum (PP) and the application of the Trendelenburg position (TP) to optimize surgical exposure. These interventions are known to increase intra-abdominal pressure and may influence venous return, intrathoracic pressure, and cerebral hemodynamics. The combined use of pneumoperitoneum and Trendelenburg positioning is considered to have the potential to increase intracranial pressure (ICP). Therefore, the intraoperative assessment of intracranial dynamics is of clinical importance.

Optic nerve sheath diameter (ONSD) measurement is a noninvasive, reproducible, and bedside-applicable method used to assess changes in intracranial pressure. ONSD is considered to correlate with ICP alterations. Cerebral oxygenation can be evaluated using near-infrared spectroscopy (NIRS), a noninvasive technique that enables continuous monitoring of cerebral tissue oxygenation.

Low-flow anesthesia is based on the reduction of fresh gas flow rates and offers several advantages, including decreased anesthetic gas consumption, preservation of heat and humidity in the respiratory tract, and reduced environmental impact. However, data regarding the effects of low-flow anesthesia on cerebral physiology and intracranial dynamics remain limited. In surgical settings where pneumoperitoneum and Trendelenburg positioning are applied, evaluating the impact of different fresh gas flow rates on intracranial pressure and cerebral oxygenation is particularly important.

This prospective, randomized study was conducted in patients scheduled for elective laparoscopic hysterectomy at Bursa City Hospital. Patients aged between 18 and 75 years with an American Society of Anesthesiologists (ASA) physical status of I-II were included. Patients meeting predefined exclusion criteria were not enrolled in the study. Written informed consent was obtained from all participants prior to inclusion.

Patients were randomized into two groups using the closed-envelope method to receive either low-flow or high-flow anesthesia. Standard monitoring, including electrocardiography, noninvasive blood pressure, peripheral oxygen saturation, and NIRS monitoring, was applied to all patients. General anesthesia induction and maintenance were performed according to standardized protocols. Mechanical ventilation was provided in volume-controlled mode, and ventilator parameters were maintained within standard ranges.

Pneumoperitoneum was established using carbon dioxide (CO₂) insufflation at a predefined pressure range and was maintained throughout the surgical procedure. Following the establishment of pneumoperitoneum, patients were placed in the Trendelenburg position at a predefined angle, which was maintained during the operation.

Optic nerve sheath diameter measurements were performed using ultrasonography with minimal pressure applied to the globe. Measurements were obtained at predefined time points. Cerebral oxygenation was continuously monitored using NIRS throughout the intraoperative period. In addition, hemodynamic and respiratory parameters, including heart rate, arterial blood pressure, end-tidal carbon dioxide (EtCO₂), and ventilatory variables, were recorded.

Within the scope of this study, the effects of low-flow and high-flow anesthesia on intracranial dynamics and cerebral oxygenation were planned to be comparatively evaluated, and the study was conducted in accordance with the predefined protocol.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

64

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 75 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria

  • Female patients aged 18-75 years
  • Scheduled for elective laparoscopic hysterectomy
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Ability to provide written informed consent

Exclusion Criteria

  • Septicemia
  • Risk of malignant hyperthermia
  • Uncontrolled diabetes mellitus
  • Chronic alcohol use
  • Prolonged fasting
  • Body mass index (BMI) > 40 kg/m²
  • Intracranial space-occupying lesions (e.g., tumors, metastases, abscesses, hematomas, aneurysms)
  • History of head trauma or cerebrovascular stroke within the preceding six months
  • Known heart failure
  • Diagnosis of glaucoma
  • Prior carotid surgery or carotid artery stenosis
  • ASA physical status ≥ III
  • Requirement for massive blood transfusion
  • Conversion from volume-controlled to pressure-controlled mechanical ventilation during surgery
  • Intraoperative conversion to open surgery
  • Patient refusal to participate

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: LOW-FLOW ANESTHESİA

Patients in this group received general anesthesia with sevoflurane. Fresh gas flow was initially set at 3 L/min until a minimum alveolar concentration (MAC) of 1.0 was achieved, after which it was reduced to 1 L/min and maintained throughout the procedure.

Patients assigned to the low-flow anesthesia group initially received a fresh gas flow of 3 L/min with a mixture of 50% oxygen and 50% air until a minimum alveolar concentration (MAC) of 1.0 was achieved. Subsequently, the fresh gas flow was reduced to 1 L/min, with oxygen and air concentrations maintained at 50-60% and 40-50%, respectively. Anesthesia was maintained with sevoflurane and a continuous remifentanil infusion.

Sperimentale: HIGH-FLOW ANESTESIA

Patients assigned to the high-flow anesthesia group received general anesthesia with sevoflurane using a fresh gas flow rate of 3 L/min throughout the procedure. A gas mixture consisting of 50% oxygen and 50% air was administered, with a target minimum alveolar concentration (MAC) of 1.0. Remifentanil was administered as a continuous intravenous infusion at 0.05-0.1 μg/kg/min

Patients assigned to the high-flow anesthesia group received a fresh gas flow of 3 L/min throughout the procedure, using a mixture of 50% oxygen and 50% air. Anesthesia was maintained with sevoflurane at a target minimum alveolar concentration (MAC) of 1.0, together with a continuous remifentanil infusion.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Optic Nerve Sheath Diameter
Lasso di tempo: 1-4 hour

To determine the differences between the two groups of trendelenburg and pneumoperitoneum, which increase intracranial pressure.

1-4 hour

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cerebral Oxygenation
Lasso di tempo: 1-4 hour

To determine the effects of low-flow and high-flow anesthesia on cerebral oxygenation in conditions that increase intracranial pressure.

1-4 hour

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 gennaio 2024

Completamento primario (Effettivo)

1 dicembre 2024

Completamento dello studio (Effettivo)

1 giugno 2025

Date di iscrizione allo studio

Primo inviato

25 marzo 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 aprile 2026

Primo Inserito (Effettivo)

7 aprile 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2023-17/2

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

Protecting patient privacy and ensuring the security of patient personal information is paramount. However, in our study, some data can be shared without compromising patient safety.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .